- Home
- SKYE vs PODC Comparison
SKYE vs PODC Comparison
Compare SKYE & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- PODC
- Stock Information
- Founded
- SKYE 2012
- PODC 2013
- Country
- SKYE United States
- PODC United States
- Employees
- SKYE N/A
- PODC N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- PODC
- Sector
- SKYE Health Care
- PODC
- Exchange
- SKYE Nasdaq
- PODC Nasdaq
- Market Cap
- SKYE 46.5M
- PODC 47.8M
- IPO Year
- SKYE N/A
- PODC N/A
- Fundamental
- Price
- SKYE $1.46
- PODC $2.28
- Analyst Decision
- SKYE Strong Buy
- PODC
- Analyst Count
- SKYE 5
- PODC 0
- Target Price
- SKYE $14.75
- PODC N/A
- AVG Volume (30 Days)
- SKYE 456.9K
- PODC 63.1K
- Earning Date
- SKYE 11-10-2025
- PODC 11-11-2025
- Dividend Yield
- SKYE N/A
- PODC N/A
- EPS Growth
- SKYE N/A
- PODC N/A
- EPS
- SKYE N/A
- PODC N/A
- Revenue
- SKYE N/A
- PODC $56,957,000.00
- Revenue This Year
- SKYE N/A
- PODC $17.39
- Revenue Next Year
- SKYE N/A
- PODC $19.94
- P/E Ratio
- SKYE N/A
- PODC N/A
- Revenue Growth
- SKYE N/A
- PODC 20.01
- 52 Week Low
- SKYE $1.14
- PODC $1.28
- 52 Week High
- SKYE $5.90
- PODC $2.94
- Technical
- Relative Strength Index (RSI)
- SKYE 37.63
- PODC 68.89
- Support Level
- SKYE $1.42
- PODC $2.08
- Resistance Level
- SKYE $1.60
- PODC $2.29
- Average True Range (ATR)
- SKYE 0.10
- PODC 0.16
- MACD
- SKYE 0.08
- PODC 0.02
- Stochastic Oscillator
- SKYE 34.63
- PODC 91.49
About SKYE Skye Bioscience Inc.
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.